Artificial intelligence aids discovery of super tight-binding antibodies
Scientists at University of California San Diego School of Medicine have developed an artificial intelligence (AI)-based strategy for discovering high-affinity antibody drugs.
Molecular & Computational biology
4 hours ago
0
53
